PE38397A1 - Terapia combinada para infeccion por vih - Google Patents
Terapia combinada para infeccion por vihInfo
- Publication number
- PE38397A1 PE38397A1 PE1996000073A PE00007396A PE38397A1 PE 38397 A1 PE38397 A1 PE 38397A1 PE 1996000073 A PE1996000073 A PE 1996000073A PE 00007396 A PE00007396 A PE 00007396A PE 38397 A1 PE38397 A1 PE 38397A1
- Authority
- PE
- Peru
- Prior art keywords
- hiv
- inhibitor
- hiv infection
- combined therapy
- aids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
SE REFIERE A LA COMBINACION DE COMPUESTOS PARA EVITAR EL DESARROLLO DE RESISTENCIA EN EL TRATAMIENTO DEL SIDA O CRS(COMPLEJO RELACIONADO AL SIDA), QUE COMPRENDE: (A+B) o (A+B+C), EN DONDE (A) ES UN INHIBIDOR DE LA PROTEASA DE VIH, CONOCIDO COMO J, DE FORMULA N-(2(R)-HIDROXI-1(S)-INDANIL)-2(R)-FENILMETIL-4-(S), HIDROXI-5-(1-(4-(3-(PIRIDILMETIL)-2(S)-N`-(T-BUTIL-CARBOXAMIDO)-PIPERAZINIL))-PENTANOAMIDA, O SUS SALES FARMACEUTICAMENTE ACEPTABLES; (B) ES UN INHIBIDOR NUCLEOSIDO DE LA TRANSCRIPTASA DE VIH, CONOCIDO COMO 3TC, DE FORMULA I; (C) ES UN INHIBIDOR NUCLEOSIDO DE LA TRANSCRIPTASA DE VIH, SELECCIONADO ENTRE AZT, ddI O ddC. ESTOS COMPUESTOS ACTUAN INHIBIENDO LA PROTEASA Y LA TRANSCRIPTASA DEL VIRUS VIH, DE TAL MANERA QUE RESULTEN VIRUS INMADUROS, DE CARACTER NO INFECCIOSOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/382,113 US6689761B1 (en) | 1995-02-01 | 1995-02-01 | Combination therapy for HIV infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE38397A1 true PE38397A1 (es) | 1997-10-09 |
Family
ID=23507574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000073A PE38397A1 (es) | 1995-02-01 | 1996-01-31 | Terapia combinada para infeccion por vih |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6689761B1 (es) |
| EP (1) | EP0806957B1 (es) |
| JP (1) | JPH10513186A (es) |
| KR (1) | KR19980701856A (es) |
| CN (1) | CN1160081C (es) |
| AR (1) | AR002957A1 (es) |
| AT (1) | ATE243519T1 (es) |
| AU (1) | AU711176B2 (es) |
| BR (1) | BR9607714A (es) |
| CA (1) | CA2211973A1 (es) |
| CO (1) | CO4700430A1 (es) |
| CZ (1) | CZ244497A3 (es) |
| DE (1) | DE69628819T2 (es) |
| DK (1) | DK0806957T3 (es) |
| DZ (1) | DZ1988A1 (es) |
| EA (1) | EA000437B1 (es) |
| EE (1) | EE03514B1 (es) |
| ES (1) | ES2200052T3 (es) |
| FI (1) | FI973184A (es) |
| HK (1) | HK1004659A1 (es) |
| HR (1) | HRP960045B1 (es) |
| HU (1) | HUP9800810A3 (es) |
| IL (1) | IL116925A (es) |
| IS (1) | IS1970B (es) |
| MX (1) | MX9705916A (es) |
| MY (1) | MY121604A (es) |
| NO (1) | NO314568B1 (es) |
| NZ (1) | NZ302153A (es) |
| PE (1) | PE38397A1 (es) |
| PL (1) | PL182742B1 (es) |
| PT (1) | PT806957E (es) |
| SA (1) | SA96160669B1 (es) |
| SK (1) | SK103797A3 (es) |
| TR (1) | TR199700735T1 (es) |
| TW (1) | TW442291B (es) |
| WO (1) | WO1996023509A1 (es) |
| YU (1) | YU49417B (es) |
| ZA (1) | ZA96722B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008539A1 (en) * | 1996-08-26 | 1998-03-05 | Chiron Corporation | Postinfection human immunodeficiency virus (hiv) vaccination therapy |
| AU6761198A (en) * | 1998-03-17 | 1999-10-11 | Julianna Lisziwiewicz | Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor |
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
| JP2003523721A (ja) | 1998-12-31 | 2003-08-12 | カイロン コーポレイション | 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用 |
| US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| US20060128733A1 (en) * | 2004-11-19 | 2006-06-15 | Boehringer Ingelheim International Gmbh | Method for treating HIV infection through co-administration of tipranavir and reverset |
| AU2006274455B2 (en) * | 2005-07-27 | 2011-06-09 | Emil Toma | Zalcitabine (DDC) boosted lamivudine (3TC) compositions for antiretroviral therapy |
| EP3565554A4 (en) * | 2017-01-04 | 2020-08-19 | Oyagen, Inc. | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
| US5254539A (en) * | 1985-08-26 | 1993-10-19 | U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health | Method of treating HIV with 2',3'-dideoxyinosine |
| US5028595A (en) * | 1987-09-18 | 1991-07-02 | Hoffmann-La Roche Inc. | Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus |
| US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| IL100502A (en) | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| CN1090186C (zh) | 1993-03-31 | 2002-09-04 | 麦克公司 | 治疗aids药物组合物中的hiv蛋白酶抑制剂 |
| IL114208A0 (en) | 1994-06-27 | 1995-10-31 | Merck & Co Inc | Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors |
-
1995
- 1995-02-01 US US08/382,113 patent/US6689761B1/en not_active Expired - Fee Related
-
1996
- 1996-01-26 IL IL11692596A patent/IL116925A/xx not_active IP Right Cessation
- 1996-01-29 ES ES96903770T patent/ES2200052T3/es not_active Expired - Lifetime
- 1996-01-29 AT AT96903770T patent/ATE243519T1/de not_active IP Right Cessation
- 1996-01-29 NZ NZ302153A patent/NZ302153A/xx unknown
- 1996-01-29 MX MX9705916A patent/MX9705916A/es not_active IP Right Cessation
- 1996-01-29 EA EA199700150A patent/EA000437B1/ru not_active IP Right Cessation
- 1996-01-29 SK SK1037-97A patent/SK103797A3/sk unknown
- 1996-01-29 WO PCT/US1996/001417 patent/WO1996023509A1/en not_active Application Discontinuation
- 1996-01-29 TR TR97/00735T patent/TR199700735T1/xx unknown
- 1996-01-29 HU HU9800810A patent/HUP9800810A3/hu unknown
- 1996-01-29 JP JP8523739A patent/JPH10513186A/ja not_active Withdrawn
- 1996-01-29 CZ CZ972444A patent/CZ244497A3/cs unknown
- 1996-01-29 EP EP96903770A patent/EP0806957B1/en not_active Expired - Lifetime
- 1996-01-29 KR KR1019970705253A patent/KR19980701856A/ko not_active Application Discontinuation
- 1996-01-29 EE EE9700165A patent/EE03514B1/xx not_active IP Right Cessation
- 1996-01-29 AU AU47748/96A patent/AU711176B2/en not_active Ceased
- 1996-01-29 BR BR9607714A patent/BR9607714A/pt not_active Application Discontinuation
- 1996-01-29 DK DK96903770T patent/DK0806957T3/da active
- 1996-01-29 PT PT96903770T patent/PT806957E/pt unknown
- 1996-01-29 DE DE69628819T patent/DE69628819T2/de not_active Expired - Fee Related
- 1996-01-29 CN CNB961929103A patent/CN1160081C/zh not_active Expired - Fee Related
- 1996-01-29 CA CA002211973A patent/CA2211973A1/en not_active Abandoned
- 1996-01-30 HR HR960045A patent/HRP960045B1/xx not_active IP Right Cessation
- 1996-01-31 MY MYPI96000349A patent/MY121604A/en unknown
- 1996-01-31 DZ DZ960029A patent/DZ1988A1/fr active
- 1996-01-31 AR ARP960101221A patent/AR002957A1/es unknown
- 1996-01-31 PE PE1996000073A patent/PE38397A1/es not_active Application Discontinuation
- 1996-01-31 ZA ZA96722A patent/ZA96722B/xx unknown
- 1996-02-01 YU YU6396A patent/YU49417B/sh unknown
- 1996-02-01 CO CO96004316A patent/CO4700430A1/es unknown
- 1996-02-06 TW TW085101447A patent/TW442291B/zh not_active IP Right Cessation
- 1996-03-12 SA SA96160669A patent/SA96160669B1/ar unknown
-
1997
- 1997-07-29 IS IS4533A patent/IS1970B/is unknown
- 1997-07-31 NO NO19973533A patent/NO314568B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973184A patent/FI973184A/fi not_active Application Discontinuation
- 1997-09-29 PL PL96321660A patent/PL182742B1/pl unknown
-
1998
- 1998-05-06 HK HK98103882A patent/HK1004659A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| CY1107626T1 (el) | Παραγωγα πυραζολιου για την θεραπεια του hiv | |
| EA199900907A1 (ru) | 4,4-дизамещенные 3,4-дигидро-2(1н)-хиназолиноны, полезные в качестве ингибиторов обратной транскриптазы вич | |
| MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
| ECSP055801A (es) | Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas | |
| NO20052887L (no) | Pyridazinonderivater som GSK-3Beta inhibitorer. | |
| NO961377L (no) | Distamycin A-analoger som antitumor eller antivirale midler | |
| DK0773943T3 (da) | Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer | |
| UY28084A1 (es) | Derivados antivirales de nucleosidos | |
| ES2133769T3 (es) | Procedimiento para la sintesis diastereoselectiva de analogos de nucleosidos. | |
| DK0594702T3 (da) | Substituerede indoler som midler mod AIDS | |
| PE38397A1 (es) | Terapia combinada para infeccion por vih | |
| AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
| MA27991A1 (fr) | Derives d'aminoquinoline et leur utilisation comme ligands d'adenosine a3 | |
| AR007997A1 (es) | Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende. | |
| ES2188801T3 (es) | 4-(1h-bencimidazol-2-yl-amino) piperidinas sustituidas utiles para el tratamiento de enfermedades alergicas. | |
| BR0314860A (pt) | Derivados de pirazol | |
| PE20040903A1 (es) | Derivados de nucleosido antivirales | |
| NO20051833L (no) | 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV. | |
| MX9300008A (es) | Nucleosidos terapeuticos. | |
| ATE374775T1 (de) | Inhibitoren des hiv-integrase-enzyms | |
| AR032373A2 (es) | Intermediarios para preparar 3-(1-piperazinil)-1,2-benzoisotiazol. | |
| BR0314709A (pt) | Derivados de pirazol | |
| BR0314759A (pt) | Derivados de pirazol | |
| DK0944618T3 (da) | Nye N-benzensulfonyl-L-prolin-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til terapeutiske formål |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |